This inventor holds 2 USPTO granted patents. Top assignee: National Defense Medical Center. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Hao-Ai Shui: Innovator in Renal Disease Diagnosis
Introduction
Hao-Ai Shui is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in renal disease. With a focus on innovative methods for disease diagnosis, he has been instrumental in advancing healthcare solutions.
Latest Patents
Hao-Ai Shui holds 2 patents that showcase his expertise in renal disease diagnosis. His latest patents include a method for renal disease diagnosis using Rab23 as a marker, which utilizes Annexin A1 or Rab23 as a biomarker for diagnosing kidney disease or assessing the efficacy of kidney disease treatment. Another notable patent is a method for renal disease diagnosis and prognosis using Annexin A1 and Rab23 as markers, further emphasizing the importance of these biomarkers in the medical field.
Career Highlights
Hao-Ai Shui is affiliated with the National Defense Medical Center, where he applies his knowledge and skills to improve diagnostic methods. His work has garnered attention for its potential impact on patient care and treatment outcomes.
Collaborations
Hao-Ai Shui collaborates with esteemed colleagues, including Shuk-Man Ka and Ann Chen. Their combined efforts contribute to the advancement of research and innovation in the field of renal disease.
Conclusion
Hao-Ai Shui's contributions to renal disease diagnosis through his innovative patents highlight his commitment to improving healthcare. His work continues to pave the way for advancements in medical diagnostics, ultimately benefiting patients worldwide.